Submitted by Anonymous (not verified) on 13 March 2025 - 14:51
Human medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Date of authorisation: 31/05/2022, Revision: 4, Status: Authorised
Source: